483
Jiangsu Baozong & Baoda Pharmachem Co., Ltd.Jiangsu Baozong & Baoda Pharmachem Co., Ltd. – FDA 483, Mar 28, 2025
Record Details
An FDA inspection of Jiangsu Baozong & Baoda Pharmachem Co., Ltd. in Nantong, China, revealed significant deficiencies in the manufacturing of Active Pharmaceutical Ingredients for Veterinary Use. Observations included inadequate control and documentation of production equipment, lack of proper cleaning and storage, and insufficient laboratory testing for API release and stability. These issues indicate a serious lack of quality control and good manufacturing practices.
- Inspection date
- March 28, 2025
- Product type
- veterinary
View Company Profile
ID · 4c1d173f-470c-4409-aa1d-51dc816988c8
Other documents for Jiangsu Baozong & Baoda Pharmachem Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.